Recent Updates
Recently added Catalysts
LEXX

Lexaria Welcomes New Medical Marijuana Expert Advisor Kelowna, BC

Key Takeaway: Lexaria Welcomes New Medical Marijuana Expert Kelowna, BC March 25, 2014 - Lexaria Corp. (LXRP-OTCQB) (LXX-CSE) (the "Company" or "Lexaria") is pleased to announce the appointment of its first medical marijuana expert to its Advisory Board. Mr Jason Springett has joined Lexar

Full Press Release Details

Lexaria Welcomes New Medical Marijuana Expert
Kelowna, BC March 25, 2014 - Lexaria Corp. (LXRP-OTCQB)
(LXX-CSE) (the "Company" or "Lexaria") is pleased to announce the
appointment of its first medical marijuana expert to its Advisory Board.
Mr Jason Springett has joined Lexaria s Advisory Board. Mr
Springett has extensive knowledge and experience in the medical marijuana sector
having been a licensed grower under existing Health Canada regulations for many
years. He has experience with multi-strain growing including THC-free CBD
strains; with both organic growing and non-toxic pest control and non organic
growing techniques; with yield optimizations strategies such as highly monitored
and controlled light, heat, CO2; remote monitoring and controls, and much more.
Mr. Springett is highly sought after as a design and training
expert for licensed medical marijuana facilities, and Lexaria is very pleased
that he has joined the Advisory Board. Mr. Springett was also a former
consultant to Cannabis Science Inc of Colorado. Mr Springett is being awarded an
honorarium of $2,000 and the granting of 50,000 stock options with an exercise
I m delighted to join Lexaria Corp, said Mr. Springett. The
Company is showing every sign of developing into a major participant in the
Canadian medical marijuana sector and I m thrilled to be involved from these
Lexaria has been building its team of experts and consultants
in all aspects of its business and expects to continue this growth in the near
Unrelated, Lexaria also reports that xxxxx stock options have
been exercised for proceeds of $ to the Company.
The securities referred to herein will not be or have not
been registered under the United States Securities Act of 1933, as amended, and
may not be offered or sold in the United States absent registration or an
applicable exemption from registration requirements.
Lexaria s shares are quoted in the USA with symbol LXRP and in
Canada with symbol LXX. The company searches for projects that could provide
potential above-market returns.
To learn more about Lexaria Corp. visit www.lexariaenergy.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements. Such forward-looking statements are
estimates reflecting the Company's best judgment based upon current information
and involve a number of risks and uncertainties, and there can be no assurance
that other factors will not affect the accuracy of such forward-looking
statements. It is impossible to identify all such factors but they include and
are not limited to the existence of underground deposits of commercial
quantities of oil and gas; cessation or delays in exploration because of
mechanical, weather, operating, financial or other problems; capital
expenditures that are higher than anticipated; or exploration opportunities
being fewer than currently anticipated. There can be no assurance that road or
site conditions will be favorable for field work; no assurance that well
treatments or workovers will have any effect on oil or gas production; no
assurance that oil field interconnections will have any measurable impact on oil
or gas production or on field operations, and no assurance that any expected new
well(s) will be drilled or have any impact on the Company. There can be no
assurance that expected oil and gas production will actually materialize; and
thus no assurance that expected revenue will actually occur. There is no
assurance the Company will have sufficient funds to drill additional wells, or
to complete acquisitions or other business transactions. Such forward looking
statements also include estimated cash flows, revenue and current and/or future
rates of production of oil and natural gas, which can and will fluctuate for a
variety of reasons; oil and gas reserve quantities produced by third parties;
and intentions to participate in future exploration drilling. Adverse weather
conditions including but not limited to surface flooding can delay operations,
impact production, and cause reductions in revenue. The Company may not have
sufficient expertise to thoroughly exploit its oil and gas properties. The
Company may not have sufficient funding to thoroughly explore, drill or develop
its properties. Access to capital, or lack thereof, is a major risk and there is
no assurance that the Company will be able to raise required working capital.
Current oil and gas production rates may not be sustainable and targeted
production rates may not occur. Factors which could cause actual results to
differ materially from those estimated by the Company include, but are not
limited to, government regulation, managing and maintaining growth, the effect
of adverse publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements and filings.
There is no assurance that the medical marijuana business will provide any
The CNSX has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.
Last updated: Mar 25, 2014